JBSAY yields 9.88% · PFE yields 6.13%● Live data
📍 JBSAY pulled ahead of the other in Year 1
Combined, JBSAY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JBSAY + PFE for your $10,000?
JBS S.A., a food company, processes and trades in animal protein worldwide. It offers beef, pork, chicken, and lamb products and by-products; food products; pet food and concentrates; and bresaola. The company also produces and commercializes steel cans, plastic resins, soap bases and bars, biodiesel, glycerin, fatty acid, collagen, and wrapper, as well as wet blue, semi-finished, and finished leather products; manages industrial residue; purchases and sells soybeans; and produces, cogenerates, and commercializes electric power. In addition, it is involved in tallow, palm oil, caustic soda, stearin, transportation, dog biscuits, hygiene and personal care, and sausage casings business; the operation of distribution centers and harbors; and the provision of cattle fattening, transportation, logistics, warehousing, and waste management and recycling services. Further, the company trades in cooked frozen meat; and operates Mercado da Carne store that provides beef and related items. It offers its products under the 1953, Doriana, Friboi, Massa Leve, Maturatta, Seara, Seara Gourmet, Swift, Angus Friboi, Anglo, Big Frango, Bordon, Confiança, delicate, Do Chef, Frangosul, Frigor Hans, LeBon, Reserva Friboi, Rezende, 1855, Incrível Seara, 5 Star, Aspen Ridge, Plumrose, Gold'n Plump, Just Bared Chicken, La Herencia, Moy Park, Pilgrim's, Primo, Rigamonti, and Swift Black. The company was formerly known as Friboi Ltda. JBS S.A. was founded in 1953 and is headquartered in São Paulo, Brazil.
Full JBSAY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.